The role of pulmonary rehabilitation in the prevention of exacerbations of chronic lung diseases

2017 ◽  
pp. 224-246
Author(s):  
Fernanda M. Rodrigues ◽  
Matthias Loeckx ◽  
Thierry Troosters ◽  
Wim Janssens
Keyword(s):  
Pulmonary Rehabilitation ◽  
Lung Diseases ◽  
Chronic Lung Diseases

scholarly journals The role of female hormones on lung function in chronic lung diseases

2011 ◽  
Vol 11 (1) ◽  
Author(s):  
Anthony Tam ◽  
Don Morrish ◽  
Samuel Wadsworth ◽  
Delbert Dorscheid ◽  
SF Paul Man ◽  
...  
Keyword(s):  
Lung Function ◽  
Lung Diseases ◽  
Chronic Lung Diseases ◽  
Female Hormones

scholarly journals CHARACTERISTICS AND ROLE OF MACROPHAGES IN PATHOGENESIS OF ACUTE AND CHRONIC LUNG DISEASES

2017 ◽  
Vol 19 (6) ◽  
pp. 657-672 ◽  
Author(s):  
A. A. Nikonova ◽  
M. R. Khaitov ◽  
R. M. Khaitov
Keyword(s):  
Lung Diseases ◽  
Chronic Lung Diseases

scholarly journals Long-Term Adherence and Maintenance of Benefits in Pulmonary Rehabilitation

2020 ◽  
Author(s):  
Hulya Sahin
Keyword(s):  
Quality Of Life ◽  
Pulmonary Rehabilitation ◽  
Lung Diseases ◽  
Functional Dependence ◽  
Daily Life Activities ◽  
Chronic Lung Diseases ◽  
Maintenance Program ◽  
Decrease Decrease

Pulmonary rehabilitation (PR) is a comprehensive intervention in chronic lung diseases, including personalized special therapies, exercise training, education and behavioral changes to improve the physical and psychological status of the patients, and aims to promote behavior that helps improve health status in the long term. A personalized PR program administered by a multidisciplinary team is recently considered a standard and complementary treatment method in chronic lung diseases. After the PR program, dyspnea of COPD patients decreases and their exercise capacities increase. Their daily life activities and physical activities increase. Their functional dependence decreases and quality of life increases. It presents a perfect opportunity to provide self-management and independence for the patients and improve their quality of life. Studies have shown that, unless there is a structured maintenance program, after an average of 6–12 months following PR programs, the gains that are realized start to decrease. Decrease of gains due to causes like a decrease in compliance to exercises, disease progress, attacks and co-morbidities. Causes such as decreased compliance to exercise, progression of the disease, attacks and comorbidities play a role in reducing gains. Especially in advanced age and in the presence of severe disease, the gain in exercise tolerance is lost more rapidly. The methods used and the results obtained to ensure the continuation of the gains differ.

About a role of particle pollution for pathogenesis of chronic lung diseases

2017 ◽  
Vol 27 (3) ◽  
pp. 404-409 ◽  
Author(s):  
Alla F. Kolpakova ◽  
Ruslan N. Sharipov ◽  
Fedor A. Kolpakov
Keyword(s):  
Lung Diseases ◽  
Chronic Lung Diseases ◽  
Particle Pollution

Proteolytic Enzymes, their Inhibitors and Lung Diseases

1983 ◽  
Vol 64 (2) ◽  
pp. 119-126 ◽  
Author(s):  
R. A. Stockley
Keyword(s):  
Proteolytic Enzyme ◽  
Lung Diseases ◽  
Enzyme Inhibitors ◽  
Proteolytic Enzymes ◽  
General Concept ◽  
Chronic Lung Diseases ◽  
High Incidence ◽  
Serum Inhibitor ◽  
Reparative Changes

The pathogenesis of many acute and chronic lung diseases remains a mystery. However, recent years have seen a rapidly increasing interest in the role of proteolytic enzymes and their inhibitors in modifying the inflammatory, destructive and reparative changes that occur in the lung. Much of this interest owes its existence to two observations in the early 1960s: firstly, the recognition that subjects with an inherited deficiency of α1-antitrypsin (α1-AT; the main serum inhibitor of proteolytic enzymes) had a high incidence of pulmonary emphysema [1], and secondly the demonstration by Gross et al. [2] that a proteolytic enzyme (papain) was capable of producing lesions similar to emphysema in experimental animals. These observations ultimately led to the proteinase—anti-proteinase theory of emphysema, which predicts that a state of balance occurs in the healthy lung in which the proteolytic enzyme inhibitors functionally equal or exceed the enzymes. Destructive lung disease occurs when the enzymes functionally exceed the inhibitors such that they remain active within the lung, resulting in digestion of connective tissue. This general concept of a disturbed proteinase—anti-proteinase balance within the lung has been recently applied to many other lung diseases, and some will be mentioned later. However, it is in the study of chronic bronchitis and emphysema that the concept has become most well established.

Pulmonary Rehabilitation In Covid-19: The Contribution Of Other Chronic Lung Syndromes For The Intervention Of A Novel Disease.

2021 ◽  
Vol 17 ◽  
Author(s):  
Vicente Benavides-Córdoba ◽  
Diana Guerrero-Jaramillo ◽  
Jhonatan Betancourt-Peña
Keyword(s):  
Quality Of Life ◽  
Functional Capacity ◽  
Pulmonary Rehabilitation ◽  
Lung Diseases ◽  
Neuromuscular Disorders ◽  
Chronic Lung Diseases ◽  
The World

COVID-19 has spread throughout the world causing a significant number of cases of pneumonia and SARS. Patients with COVID-19 may also have other cardiovascular, respiratory, and neuromuscular disorders. These multisystemic complications present the need for comprehensive interventions focused on improving symptoms, functional capacity, and quality of life. Pulmonary rehabilitation has the potential to offer some of these benefits. However, the evidence related to specific aspects of pulmonary rehabilitation evaluation and intervention in COVID19 is limited. We have learned from experiences with other types of chronic lung diseases that have used pulmonary rehabilitation successfully, so that while the own evidence of rehabilitation emerges in COVID-19, it is necessary to establish some initial recommendations, prepared according to the sequelae found until now.

Sign in / Sign up

Export Citation Format

Share Document